MORGAN STANLEY

Holdings History for Apogee Therapeutics, Inc. - COMMON STOCK (APGE)

Symbol: APGE on Nasdaq
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$67,197,243	890,264	+425,301	+91%	$75.48	Q4 2025
30 Sep 2025	0%	-0%	$18,473,006	464,963	-9,739	-2.1%	$39.73	Q3 2025
30 Jun 2025	0%	-0%	$20,616,337	474,702	-45,237	-8.7%	$43.43	Q2 2025
31 Mar 2025	0%	+0%	$19,424,957	519,939	+310,405	+100%	$37.36	Q1 2025
31 Dec 2024	0%	-0%	$9,491,898	209,534	-28,736		$45.30	Q4 2024
30 Sep 2024	0%	+0%	$13,996,036	238,270	+3,491		$58.74	Q3 2024
30 Jun 2024		0%	$64	1	0		$64.00 ^*	Q2 2024
30 Jun 2024	0%	+0%	$9,238,554	234,779	+98,641		$39.35	Q2 2024
31 Mar 2024	0%	+0%	$9,046,371	136,138	+68,439	+101%	$66.45	Q1 2024
31 Dec 2023	0%	+0%	$1,891,510	67,699	+36,217	+115%	$27.94	Q4 2023
30 Sep 2023	0%	+0%	$670,567	31,482	+31,482	NEW	$21.30	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.